English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduCenter will address psychosocial impact of COVID-19 among frontline health workers; Focus is on screening, treatment, and research
Tag: Mount Sinai Health System
Mount Sinai Researchers Collaborate with GenScript to Develop a COVID-19 Antibody to Treat Sick Patients
The highly targeted antibody may block the coronaviruses’ ability to enter human lung cells
Raising Mount Sinai
The musicians of Carnegie Hall, featuring a song and words of support by Jimmy Buffet and others join forces to raise money for the front-line health care staff at the Mount Sinai Health System
Mount Sinai’s Blood Test to Detect Antibodies to COVID-19 Receives Emergency Use Authorization From U.S. Food and Drug Administration
Today, the Mount Sinai Laboratory (MSL), Center for Clinical Laboratories received emergency use authorization from the U.S. Food and Drug Administration (FDA) for an antibody test that was developed, validated, and launched at Mount Sinai by a team of internationally renowned researchers and clinicians of the Icahn School of Medicine at Mount Sinai. This test detects the presence or absence of antibodies to SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19) and importantly, may also be used to identify positive specimens with an antibody titer (level) up to a dilution of 1:2880 for the identification of individuals with higher antibody titers.
Mount Sinai Study Finds COVID-19 May Be Driven by Pulmonary Thrombi and Pulmonary Endothelial Dysfunction
A new study from the Icahn School of Medicine at Mount Sinai suggests that blood clots, especially in the lungs, may play a role in severe cases of COVID-19.
Mount Sinai Launches Personalized Online Learning Platform for Nurses on the Front Line of COVID-19 Fight
Project Florence enhances skills of nurses serving critically ill patients; curriculum is free to hospitals worldwide
Mount Sinai Launches App and First Campaign of The Resilience Project to Develop New Treatments and Preventive Care for Diseases
Lyme Campaign Seeks Participants Who Are ‘Resilient’ to the Tick-borne Disease
Breakthrough Technology Used to Discover Eye Damage from Repeated Intravitreal Injections
FOR IMMEDIATE RELEASE Contact: Ilana NikraveshMount Sinai Press [email protected] Breakthrough Technology Used to Discover Eye Damage from Repeated Intravitreal Injections Findings may lead to new treatment approaches to counteract this problem (New York, NY – April 13, 2019) – In…
Immunotherapy Treatment Immediately After Chemotherapy Significantly Slows Metastatic Bladder Cancer Progression
Using immunotherapy immediately after chemotherapy treatment in patients with metastatic bladder cancer significantly slowed the progression of the cancer, according to results of a clinical trial led by Mount Sinai researchers published in the Journal of Clinical Oncology in April.
Mount Sinai Researchers Discover a Novel Role for Dopamine That Impacts Gene Expression Related to Cocaine Abuse
Scientists at the Icahn School of Medicine at Mount Sinai have discovered a new role for the brain chemical dopamine that is independent of classic neurotransmission. The new role appears to be critical to changes in gene expression related to chronic exposure to, or abuse of, cocaine, according to a study published Friday, April 10, in the journal Science.
Mount Sinai Study Finds First Cases of COVID-19 in New York City are Primarily from European and US Sources
First definitive molecular epidemiology study of SARS-CoV-2 in New York City to describe the route by which the virus arrived
Mount Sinai Uses Remote Patient Monitoring to Rapidly Respond to COVID-19
A new remote monitoring platform developed by the Mount Sinai Health System is helping health care providers to care for COVID-19 patients who are recovering at home.
Researchers Find That Nicotinamide May Help Treat Fibrotic Eye Diseases and Mitigate Vision Loss
Nicotinamide can inhibit aggressive cell transformations during wound healing and may be key to the development of therapies to treat fibrotic eye diseases
Mount Sinai Launches COVID-19 App to Track Spread of Virus Across New York City
STOP COVID NYC Seeks Participation to Understand Transmission and Enhance Medical Response
Samaritan’s Purse, in Collaboration with Mount Sinai Health System, Opens Emergency Field Hospital in New York’s Central Park in Response to the Coronavirus Pandemic
International Christian Relief Organization Responds at Epicenter in U.S. and Italy
Mount Sinai’s Road to Resilience Podcast Launches Special COVID-19 Series
Features inspiring resilience stories, tips for maintaining mental and physical health, and thoughts on coping with pandemic-related stressors.
Mount Sinai Developing an “End-to-End” Diagnostics Solution for COVID-19 That Incorporates Diagnosis, Treatment Selection, and Monitoring of Disease Course
An expert team of researchers and clinicians have been working together to design, validate, and implement an “end-to-end” clinical pathology laboratory solution that will allow for the testing of approximately several hundred people per day in order to rapidly diagnose and help guide the selection of treatment and monitor disease course.
For Every 50 Smokers – One Non-Smoker Dies from Secondhand Smoke Exposure
New data analysis could change smoking policies worldwide to protect non-smokers and reduce their risk
Mount Sinai Health System Appoints Niyum Gandhi as New Chief Financial Officer
Mr. Gandhi, who has served as Executive Vice President and Chief Population Health Officer at Mount Sinai since 2015, succeeds Donald Scanlon, who will step down from his position later this year and will assist with the transition.
Sound Can Directly Affect Balance and Lead to Risk of Falling
Mount Sinai research highlights the need for more hearing checks among groups at high risk for falls
Rachel Vreeman Appointed Chair of Global Health and Director of the Arnhold Institute for Global Health at the Icahn School of Medicine at Mount Sinai
Appointment Enhances Efforts by the Institute to Improve Health of Communities Locally and Internationally
Mount Sinai and Harbour BioMed Collaborate to Advance Novel Biotherapies for the Treatment of Cancer and Coronavirus COVID-19
Collaboration combines Harbour BioMed’s proprietary H2L2 Harbour Mice® platform for fully human monoclonal antibody generation with Mount Sinai’s translational medical research expertise.
Mount Sinai Health System Names New Creative and Media Agencies of Record
SS+K and Mediassociates announced after months-long search
Artificial Intelligence Can Scan Doctors’ Notes to Distinguish Between Types of Back Pain
Mount Sinai researchers have designed an artificial intelligence model that can determine whether lower back pain is acute or chronic by scouring doctors’ notes within electronic medical records, an approach that can help to treat patients more accurately, according to a study published in the Journal of Medical Internet Research in February.
Mount Sinai Researchers Discover New Approach for Use of Stem Cells to Improve Bone Marrow Transplantation
Mount Sinai researchers have discovered a way to enhance the potency of blood-forming stem cells, potentially opening the door to a new approach for bone marrow transplantation.
Mount Sinai Physicians the First in U.S. Analyzing Lung Disease in Coronavirus (COVID-19) Patients from China
Findings from CT scans provide new insight that could lead to quicker diagnosis
Mount Sinai Unveils New Comprehensive Adult Congenital Heart Disease Center
New center will help fill national gap in transition of patient care from adolescence to adulthood
Mount Sinai Discovers New Drug Combo to Induce High Rates of Human Beta Cell Regeneration
Researchers at the Icahn School of Medicine at Mount Sinai have discovered a novel combination of two classes of drugs that, together, cause the highest rate of proliferation ever observed in adult human beta cells—the cells in the pancreas that produce insulin—without harming most other cells in the body. The result is an important step toward a diabetes treatment that restores the body’s ability to produce insulin.
Mount Sinai St. Luke’s Renamed Mount Sinai Morningside
New name clarifies the key role the hospital plays in the Mount Sinai Health System, honors the community the hospital serves, and reflects the considerable investments that have brought technologically advanced Mount Sinai-level care to the residents of Upper Manhattan, Westchester, New Jersey, and beyond.
Lower Stress, Stay Optimistic, and Avoid Heart Attacks
Mount Sinai Cardiologists Talk Prevention for American Heart Month
Researchers Identify Opportunities to Advance Genomic Medicine
New Study Highlights Milestones in the History of Genetic Discoveries; Equitable and Fair Access Required to Address Disparities
Icahn School of Medicine at Mount Sinai Announces Recipients of Nation’s First Gender Equity Grants
Annual Distinguished Scholar Award Aims to Break Down Barriers to Equity in Medical Research
Mount Sinai Named Among Nation’s Top Health Care Employers for Diversity by Forbes
The Mount Sinai Health System has once again been ranked among America’s “Best Employers for Diversity” by Forbes and research firm Statista.
Global Team Enables Child With a Fatal Genetic Disease to Recover
A young boy with a rare genetic disease that typically kills within weeks of birth is now 3 years old and in remission thanks to a collaborative effort that included physicians at King Saud University Department of Pediatrics and immunologists at the Icahn School of Medicine at Mount Sinai.
Preventing the “Silent Thief of Sight”
Mount Sinai Doctors Share Tips for Early Detection during Glaucoma Awareness Month
Mount Sinai Diversity Innovation Hub Named Among Top 50 Leaders in Digital Health for 2020
The Diversity Innovation Hub (DIH) at the Icahn School of Medicine at Mount Sinai is among the Top 50 in Digital Health for 2020.
Brain Cancer Expert Joins Neurosurgery Faculty at Mount Sinai
Dolores Hambardzumyan, PhD, MBA, has been appointed Senior Faculty in the Department of Neurosurgery and a member of The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai.
Researchers Find Minimally Invasive Procedure to Treat Chronic Achilles Tendon Disorder Improves Patient Outcomes and Reduces Recovery Time
A minimally invasive procedure to treat a common foot and ankle disorder can reduce pain, recovery time, and postsurgery complications while improving functional outcomes.
Mount Sinai Receives More Than $10 Million in Grant Funding for Brain Tumor Research
The Department of Neurosurgery at the Icahn School of Medicine at Mount Sinai has received more than $10 million in federal funding for several projects focusing on brain tumor research.
Researchers Identify Potential Formula for Blood Cancer Vaccine
Researchers at the Icahn School of Medicine at Mount Sinai have discovered a way to move precision immunotherapy forward by using genomics to inform immunotherapy for multiple myeloma, a blood cancer, according to a study published in Clinical Cancer Research, a journal of the American Association for Cancer Research, in December.
Caring for Transgender Persons: What Clinicians Should Know
The New England Journal of Medicine review by Mount Sinai experts will serve as a major resource and guide for all physicians looking for best care strategies
Genetic Breakthrough Identifies Heart Failure Risk in African and Latino Americans
Findings may inform genetic screening test for patients at risk and medically under-served
Mone Zaidi, MD, PhD, Named Fellow of the American Association for the Advancement of Science
Mone Zaidi, MD, PhD, Director of the Mount Sinai Bone Program, has been named a Fellow of the American Association for the Advancement of Science (AAAS)
Mount Sinai Researchers Uncover New Molecular Drivers of Parkinson’s Disease
New Approach Will Lead to a Better Understanding of Most Cases
Mount Sinai Announces Expanded Capability in Medical Research
New “big omics” supercomputer will speed up solutions; insights will lead to advances in a wide range of complex diseases
Mount Sinai Researcher’s Examine the Metabolic Effects of an Oral Blood Cancer Drug
Recent study found that an effective blood cancer treatment was associated with weight gain, obesity, and increased systolic blood pressure
Teaching Preschool Caregivers about Healthy Behaviors May Promote Healthier Lifestyle in Some High-Risk Groups
Study Shows Vascular Ultrasounds and Adhering to Interventional Education in Underserved Communities can Improve Health among Parents and School Staff
Mount Sinai Researchers Develop Novel Method to Identify Patterns Among Patients With Multiple Chronic Conditions
A study by researchers at Icahn School of Medicine at Mount Sinai proposes a novel method for identifying patterns in the frequency and cost of multiple chronic conditions (MCC).
Human Immune Monitoring Center at Mount Sinai to analyze the effectiveness of a novel cancer therapy drug
The Human Immune Monitoring Center (HIMC) at the Icahn School of Medicine at Mount Sinai will apply cutting-edge high-throughput technologies to evaluate the therapeutic effects of Libtayo® (cemiplimab-rwlc), a PD-1 antibody blockade developed by biotechnology company Regeneron Pharmaceuticals, Inc and Sanofi.
Mount Sinai Brooklyn Launches FastER Track Program in the Emergency Department
FastER Track will provide rapid access to care for low-acuity conditions, such as sore throats, rashes, and common colds.